Dalhousie Square Medical & Research Centre Profile
Key Indicators
- Authorised Capital ₹ 2.50 M
as on 24-10-2024
- Paid Up Capital ₹ 2.34 M
as on 24-10-2024
- Company Age 25 Year, 2 Months
- Last Filing with ROC 31 Mar 2024
- Revenue %
(FY 2023)
- Profit 25.83%
(FY 2023)
- Ebitda 28.81%
(FY 2023)
- Net Worth -0.06%
(FY 2023)
- Total Assets -0.02%
(FY 2023)
About Dalhousie Square Medical & Research Centre
The Company is engaged in the Healthcare Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 2.50 M and a paid-up capital of Rs 2.34 M, as per Ministry of Corporate Affairs (MCA) records.
Somnath Samanta and Ravish Sharma serve as directors at the Company.
- CIN/LLPIN
U33125WB1999PTC090380
- Company No.
090380
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
01 Oct 1999
- Date of AGM
30 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Kolkata
Industry
Company Details
- Location
Kolkata, West Bengal, India
- Telephone
- Email Address
- Website
-
- Social Media-
Who are the key members and board of directors at Dalhousie Square Medical & Research Centre?
Board Members(2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Somnath Samanta  | Director | 24-Feb-2010 | Current |
| Ravish Sharma | Director | 10-Feb-2024 | Current |
Financial Performance of Dalhousie Square Medical & Research Centre.
Dalhousie Square Medical & Research Centre Private Limited, for the financial year ended 2023, experienced no change in revenue, with a 0% increase. The company also saw a substantial improvement in profitability, with a 25.83% increase in profit. The company's net worth dipped by a decrease of 0.06%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue | |||||||
| Revenue from Operations | |||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Dalhousie Square Medical & Research Centre?
In 2023, Dalhousie Square Medical & Research Centre had a promoter holding of 100.00%. The company had 1 Subsidiary. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
- Square Four Projects India LimitedActive 32 years 6 months
Somnath Samanta and Ravish Sharma are mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Dalhousie Square Medical & Research Centre?
Unlock and access historical data on people associated with Dalhousie Square Medical & Research Centre, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Dalhousie Square Medical & Research Centre, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Dalhousie Square Medical & Research Centre's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
